- Previous Close
0.0000 - Open
-- - Bid 1.3400 x 29200
- Ask 141.3300 x 41800
- Day's Range
-- - 52 Week Range
1.7500 - 1.7500 - Volume
-- - Avg. Volume
0 - Market Cap (intraday)
250.423M - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
nightingalehealth.com94
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: NGHLF
View MorePerformance Overview: NGHLF
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is OMX Helsinki_PI (^OMXHPI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NGHLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NGHLF
View MoreValuation Measures
Market Cap
196.00M
Enterprise Value
129.90M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-12.91%
Return on Equity (ttm)
-20.65%
Revenue (ttm)
4.95M
Net Income Avi to Common (ttm)
-17.14M
Diluted EPS (ttm)
-0.3300
Balance Sheet and Cash Flow
Total Cash (mrq)
59.71M
Total Debt/Equity (mrq)
2.25%
Levered Free Cash Flow (ttm)
-4.83M